Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Neurocrine Biosciences, Inc. company logo
Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc. (NBIX)

Summary

As of today, NBIX price is $128.13, down -1.16% on
NBIX price is currently -20.01% below its historical high of $160.18 set on
NBIX current market cap is $13B, up +13.73% over the past 365 days
NBIX current PE ratio is 27.45
NBIX current annual revenue is $2.86B, up +21.45% year-over-year
The next earnings release for NBIX is on

Profile

Company profile for Neurocrine Biosciences, Inc. (NBIX)
MetricValue
Full NameNeurocrine Biosciences, Inc.
TickerNASDAQ: NBIX
ExchangeNASDAQ
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryUnited States
IPO
IndexesNot included
Websiteneurocrine.com
Employees1,800

Key Metrics

Neurocrine Biosciences, Inc. Key Details
MetricDateValue
Price$128.13
Price, 1D Change-1.16%
Market Cap$13B
-
PE Ratio27.45
Beta0.85
Revenue$3B
Revenue, 1Y Change+21.45%
EPS$4.67
EPS, 1Y Change+41.87%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Neurocrine Biosciences, Inc. chart

Events

Neurocrine Biosciences, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

NBIX Estimates
MetricDateValue
EPS$4.67
EPS EstimateN/A$7.95
EPS Est. ChangeN/A+70.30%
Revenue$2.86B
Revenue EstimateN/A$3.44B
Revenue Est. ChangeN/A+20.42%
Current Price$128.13
Price Target-$175.50
Price Tgt. Change-+36.97%

🔒 Log In To Unlock Full Data

EPS

NBIX EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$6.58$3.29-49.95%
$6.81$4.67-31.48%
$7.95N/A+70.30%
$9.58N/A+105.23%
NBIX EPS reported versus estimate values chart

Revenue

NBIX revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$2.36B$2.36B-0.04%
$2.84B$2.86B+0.58%
$3.44BN/A+20.42%
$3.80BN/A+32.75%
NBIX revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

NBIX Performance
MetricDateValue
Price, 1Y+13.73%
Price, 3Y+27.20%
Market Cap, 1Y+13.73%
Market Cap, 3Y+31.31%
Revenue, 1Y+21.45%
Revenue, 3Y+92.15%
EPS, 1Y+41.87%
EPS, 3Y+198.89%

🔒 Log In To Unlock Full Data

Technical Indicators

NBIX Technical Indicators
MetricDateValue
Current Price$128.13
SMA 200$136.61
SMA 200 vs Price+6.62%
SMA 50$135.14
SMA 50 vs Price+5.47%
Beta0.85
ATR$3.85
14-Day RSI41.16
10-Day Volatility23.17%
1-Year Volatility34.22%

Dividends

NBIX Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

NBIX Income & Profitability
MetricDateValue
Revenue$2.86B
EPS$4.67
Gross Profit$2.81B
Gross Margin98.18%
Operating Profit$636.50M
Operating Margin22.25%
Net Income$478.60M
Net Margin16.73%
EBITDA$666.60M

🔒 Log In To Unlock Full Data

Financial Health

NBIX Financial Health
MetricDateValue
Debt To Equity0.14
3.39
3.30
-
7
6.73

Valuations

NBIX Valuations
MetricDateValue
PE Ratio27.45
4.47
3.93
17.65
N/A-

Balance Sheet

NBIX Balance Sheet
MetricDateValue
Book Value$3.25B
$1.48B
$4.75B
$2.52B
$1.50B
$743.40M
Total Debt$471.30M
$56.00M
$104.90M

Expenses

NBIX Expenses
MetricDateValue
$2.38B
$2.17B
$52.10M
$0.00
$30.10M
$0.00
$226.80M

Cash Flow

NBIX Cash Flow
MetricDateValue
$782.70M
-$264.40M
-$38.30M
Capex$34.00M
$748.70M

Recent analyst updates

NBIX Recent analyst updates
MetricDateValue
Wolfe Research
Truist Securities→
JP Morgan→
Wells Fargo→
Wedbush→
RBC Capital→
Needham→
HC Wainwright & Co.→
Citigroup→
BMO Capital→

Analyst sentiment

Sentiment over the past month
NBIX analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
NBIX institutional ownership distribution chart

Screeners with NBIX

FAQ

  • What is the ticker symbol for Neurocrine Biosciences, Inc.?

    The ticker symbol for Neurocrine Biosciences, Inc. is NASDAQ:NBIX

  • Does Neurocrine Biosciences, Inc. pay dividends?

    No, Neurocrine Biosciences, Inc. does not pay dividends

  • What sector is Neurocrine Biosciences, Inc. in?

    Neurocrine Biosciences, Inc. is in the Healthcare sector

  • What industry is Neurocrine Biosciences, Inc. in?

    Neurocrine Biosciences, Inc. is in the Specialty & Generic Drug Manufacturers industry

  • What country is Neurocrine Biosciences, Inc. based in?

    Neurocrine Biosciences, Inc. is headquartered in United States

  • When did Neurocrine Biosciences, Inc. go public?

    Neurocrine Biosciences, Inc. initial public offering (IPO) was on May 23, 1996

  • Is Neurocrine Biosciences, Inc. in the S&P 500?

    No, Neurocrine Biosciences, Inc. is not included in the S&P 500 index

  • Is Neurocrine Biosciences, Inc. in the NASDAQ 100?

    No, Neurocrine Biosciences, Inc. is not included in the NASDAQ 100 index

  • Is Neurocrine Biosciences, Inc. in the Dow Jones?

    No, Neurocrine Biosciences, Inc. is not included in the Dow Jones index

  • When was Neurocrine Biosciences, Inc. last earnings report?

    Neurocrine Biosciences, Inc.'s most recent earnings report was on February 11, 2026

  • When does Neurocrine Biosciences, Inc. report earnings?

    The next expected earnings date for Neurocrine Biosciences, Inc. is May 4, 2026

Data Sources & References

  1. NBIX Official Website www.neurocrine.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/914475/000091447526000007/0000914475-26-000007-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/914475/000091447526000007/0000914475-26-000007-index.htm
  4. NBIX Profile on Yahoo Finance finance.yahoo.com/quote/NBIX
  5. NBIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbix